Full-Time
Senior Oracle Cloud Infrastructure Database Administrator
Posted on 11/23/2025
ZOLL Medical Corporation
1,001-5,000 employees
Cardiac resuscitation devices with integrated software
Compensation Overview
$125k - $150k/yr
No H1B Sponsorship
Lowell, MA, USA
In Person
US Citizenship, US Top Secret Clearance, UK Citizenship Required
 DevOps & Infrastructure (1) |
|---|
- Bachelor's Degree Computer Science or similar required
- 10+ years Oracle E-Business Suite (11i/R12) and/or Oracle Fusion Cloud
- Minimum five (5) years in Oracle Fusion Cloud
- Minimum 5 years of experience working with Fusion Cloud, Software as a Service, Infrastructure as a Service and Platform as a Service on Oracle Cloud Infrastructure
- Strong experience in Fusion Cloud implementations and production support
- Ability to design and configure solutions based on changing business needs including documenting requirements and creating technical specifications in Oracle Cloud Infrastructure
- Experience in migration activities between various Cloud Instances and between on-premises to Oracle Cloud Infrastructure
- Work effectively on multiple activities and projects
- Strong analytical and training skills
- Troubleshoot production and non-production issues on premises and in Oracle Cloud Infrastructure
- Determine the architecture and deployment strategy for Fusion Cloud applications and databases on Oracle Cloud Infrastructure, considering factors like performance, availability, and security
- Experience with Oracle Integration Cloud, Fusion SaaS, Oracle Application Express, Fusion Analytics and Visual Builder Cloud Service Administration, Oracle Cloud Infrastructure Identity and Access Management Federated Single Sign-On as well as Oracle Cloud Infrastructure, deep understanding of the Oracle Infrastructure as a Service / Platform as a Service infrastructure, solid problem solving and time management skills
- Knowledgeable in Software as a Service & Platform as a Service Integration (Cloud ERP, Oracle Integration Cloud, Application Express, Fusion Activity Writer etc.)
- Diagnoses, troubleshoots, and resolve complex integration and application issues, collaborating closely with Oracle Support and cross-functional internal teams
- Implemented Multi-Factor Authentication for the Fusion Software as a Service Supplier Portal using Oracle Cloud Infrastructure Identity and Access Management Domain Federated Single Sign-On/Security Assertion Markup Language, and established Network-Based Access Control for Fusion Software as a Service
- Experience with cloning activities for ERP Cloud Production-to-Test environments refresh, validating post-cloning processes for Employee Self Service jobs, sandbox management, proficiency in using data loader and File-Based Data Import for user provisioning and data security assignments
- Good knowledge of Common Unix Printing System administration and problem solving of printer issues on premises as well as in Oracle Cloud Infrastructure
- Establish and manage connectivity between the Fusion Software as a Service applications and the Oracle Cloud Infrastructure Application Express and Fusion Analytics databases, ensuring secure and reliable access
- Perform routine administrative tasks, such as managing users, permissions, and security policies for Application Express, Fusion Analytics and Database Cloud Services databases in production and non-production environments both on-premises as well as in Oracle Cloud Infrastructure
- Implement robust backup and recovery procedures for both on-premises and cloud databases, ensuring data protection and disaster recovery capabilities
- Implement security measures to protect Cloud databases from unauthorized access and potential threats, including encryption, access control, and auditing
- Experience in Fusion Analytics
- Experience in Oracle E-Business Suite R11i/R12
ZOLL Medical Corporation designs and sells medical devices and software for emergency and critical care. Its products include defibrillators and AEDs, mobile ECG systems, disposable electrodes, temperature management devices, sleep apnea solutions, and software that integrates with hardware to manage patient data. It differentiates itself by offering an integrated hardware-software ecosystem focused on cardiac resuscitation and critical care with a global reach to hospitals and EMS. Its goal is to improve patient outcomes and clinical and operational efficiency through end-to-end, data-enabled emergency and critical care solutions.
Company Size
1,001-5,000
Company Stage
Acquired
Total Funding
$2.2B
Headquarters
Chelmsford, Massachusetts
Founded
1980
Simplify's Take
What believers are saying
- Eric Knudsen's CEO appointment drives growth from 30 years medtech expertise.
- ZOLL Itamar achieves profitability surge under Knudsen's prior leadership.
- EU MDR approval expands Zenix sales in Europe for hospitals and EMS.
What critics are saying
- Medtronic LifePak captures 45% US EMS share, eroding X Series sales.
- Stryker LUCAS 4 beats AutoPulse NXT by 18% ROSC in 2025 AHA trials.
- ResMed NightOwl halves ZOLL Itamar's $200M sleep diagnostics revenue.
What makes ZOLL Medical Corporation unique
- Zenix defibrillator offers Real CPR Help and touchscreen customization for EMS.
- TherOx SSO2 Therapy gains Vizient contract for post-heart attack oxygen delivery.
- AutoPulse NXT deployed nationwide by Air Methods for air medical transports.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Casual Work Environment
Company News
ZOLL, an Asahi Kasei company manufacturing medical devices, has announced that its Zenix monitor/defibrillator received approval under the European Union Medical Device Regulation 2017/745. The device is designed for use in both emergency medical services and hospital settings. Zenix features a large touchscreen and on-the-fly customisation capabilities, allowing healthcare professionals to make real-time adjustments during critical situations. The device incorporates ZOLL's Real BVM Help and Real CPR Help technology, providing clinical feedback to improve ventilation quality and CPR delivery. According to Elijah White, president of ZOLL Acute Care Technology, virtually all device functions are accessible with three screen-touches or fewer. Zenix joins ZOLL's existing portfolio of professional monitors and defibrillators, including the X Series, R Series and M2 models.
ZOLL medical appoints Eric Knudsen as new CEO. CHELMSFORD, Mass. - (BUSINESS WIRE) - ZOLL(R), an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL's CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL's Board of Directors. "As a global leader in medical technology, ZOLL is continually looking for ways to expand our business and reach more patients in need," said Rennert. "Eric has played a unique role in developing our growth strategies and driving our expansion, and I am confident he will lead ZOLL to even greater growth and success." "I am honored to become ZOLL's next CEO," said Knudsen. "ZOLL has a long legacy of innovation and clinical excellence, and today our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. We will continue to lead with our commitment to patients and customers and our passion for improving outcomes and helping save lives." Knudsen has nearly 30 years of experience in the medtech industry, with deep expertise in business development and corporate strategy. He led ZOLL's Corporate Development team for six years and was responsible for investing in strategic relationships and acquiring more than a dozen new technologies. For the past four years, Knudsen was President of ZOLL Itamar, a division of ZOLL that is focused on the diagnosis of sleep disorders. Knudsen led the division through significant growth and a dramatic increase in profitability. Prior to joining ZOLL in 2013, Knudsen held leadership positions in international sales, marketing, and manufacturing partnerships at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He has an MBA from the Thunderbird School of Global Management and a bachelor's degree from Boston College. Rennert was named CEO of ZOLL in 2016, after serving as President of the company's largest business unit for eight years. Under Rennert's leadership as CEO, ZOLL expanded its reach as a global leader in external defibrillation, pioneered novel solutions for patients with serious cardiopulmonary and respiratory conditions, and significantly broadened its portfolio of products. About ZOLL ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com. About Asahi Kasei The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com. Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/. Matt Hogan ZOLL 978-805-6561 [email protected]
Air Methods collaborated closely with ZOLL to provide direct feedback during the development of the AutoPulse NXT, which was released in 2024.
The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.
Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...